CYP2D6 gene
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| opioid | targets | CYP2D6 | — | 1 |
| slow metabolizer | associated_with | CYP2D6 | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Genome-wide association testing beyond SNPs. (2025)
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- Expansion of Schizophrenia Gene Network Knowledge Using Machine Learning Selected Signals From Dorsolateral Prefrontal Cortex and Amygdala RNA-seq Data. (2022)
- What Should a Psychiatrist Know About Genetics? Review and Recommendations From the Residency Education Committee of the International Society of Psychiatric Genetics. (2018)
- Extending reference assembly models. (2015)
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cyp2d6 | gene | 7 | 11 |
| cytochrome p450 2d6 | gene | — | — |